Navegar

Colección

Datos Estadísticas

Lista de

cancer growth
39
"Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk" (2018) Orozco, C.A.;Martinez-Bosch, N.;Guerrero, P.E. (...)Navarro, P. Proceedings of the National Academy of Sciences of the United States of America. 115(16):E3769-E3778
"Microenvironmental influence on microtumour infiltration patterns: 3D-mathematical modelling supported by: In vitro studies" (2018) Luján, E.;Soto, D.;Rosito, M.S. (...)Suárez, C. Integrative Biology (United Kingdom). 10(5):325-334
"Game-changing restraint of Ros-damaged phenylalanine, upon tumor metastasis article" (2018) Gueron, G.;Anselmino, N.;Chiarella, P. (...)Vazquez, E. Cell Death and Disease. 9(2)
"R-Spondin3 is associated with basal-progenitor behavior in normal and tumor mammary cells" (2018) Tocci, J.M.;Felcher, C.M.;García Sola, M.E. (...)Kordon, E.C. Cancer Research. 78(16):4497-4511
"Human renal adipose tissue induces the invasion and progression of renal cell carcinoma" (2017) Campo-Verde-Arbocco, F.;López-Laur, J.D.;Romeo, L.R. (...)Creydt, V.P. Oncotarget. 8(55):94223-94234
"Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations" (2017) Luce, L.N.; Abbate, M.; Cotignola, J.; Giliberto, F. Oncotarget. 8(1):145-155
"The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies" (2016) Sterle, H.A.;Barreiro Arcos, M.L.;Valli, E. (...)Cremaschi, G.A. Journal of Molecular Medicine. 94(4):417-429
"Role of RSUME in inflammation and cancer" (2015) Antico Arciuch, V.G.; Tedesco, L.; Fuertes, M.; Arzt, E. FEBS Letters. 589(22):3330-3335
"Thyroid status modulates T lymphoma growth via cell cycle regulatory proteins and angiogenesis" (2014) Sterle, H.A.;Valli, E.;Cayrol, F. (...)Barreiro Arcos, M.L. Journal of Endocrinology. 222(2):243-255
"Differential effect of heterocyclic d-ribofuranoside derivatives on human prostate cancer cell viability and cell cycle progression" (2014) Gueron, G.;Avanzo, R.E.;Schuster, F. (...)D'Accorso, N.B. Biomedicine and Pharmacotherapy. 68(7):847-854
"Glutathione-S-transferase (GST) polymorphisms are associated with relapse after radical prostatectomy" (2013) Cotignola, J.;Leonardi, D.B.;Shahabi, A. (...)Vazquez, E. Prostate Cancer and Prostatic Diseases. 16(1):28-34
"Delineating the "galectin signature" of the tumor microenvironment" (2013) Compagno, D.;Laderach, J.D.;Gentilini, L. (...)Rabinovich, A.G. OncoImmunology. 2(4)
"A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease" (2013) Laderach, D.J.;Gentilini, L.D.;Giribaldi, L. (...)Rabinovich, G.A. Cancer Research. 73(1):86-96
"Vascular galectins: Regulators of tumor progression and targets for cancer therapy" (2013) Thijssen, V.L.; Rabinovich, G.A.; Griffioen, A.W. Cytokine and Growth Factor Reviews. 24(6):547-558
"The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide" (2012) Zacarías Fluck, M.F.;Hess, L.;Salatino, M. (...)Scharovsky, O.G. Cancer Immunology, Immunotherapy. 61(4):469-480
"Advanced prostate cancer: Reinforcing the strings between inflammation and the metastatic behavior" (2012) Gueron, G.; De Siervi, A.; Vazquez, E. Prostate Cancer and Prostatic Diseases. 15(3):213-221
"The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins " (2012) Lanari, C.;Giulianelli, S.;Vaqué, J.P. (...)Gutkind, J.S. Medicina (Argentina). 72(4):315-320
"Key questions in metastasis: New insights in molecular pathways and therapeutic implications" (2011) Gueron, G.; de Siervi, A.; Vazquez, E. Current Pharmaceutical Biotechnology. 12(11):1867-1880
"Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects" (2011) Bottino, M.C.;Cerliani, J.P.;Rojas, P. (...)Lanari, C. Breast Cancer Research and Treatment. 126(3):621-636
"Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer" (2011) Chauchereau, A.;Al Nakouzi, N.;Gaudin, C. (...)Fizazi, K. Experimental Cell Research. 317(3):262-275
"Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells" (2009) Gueron, G.;De Siervi, A.;Ferrando, M. (...)Vazquez, E.S. Molecular Cancer Research. 7(11):1745-1755
"Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth" (2009) Proietti, C.J.;Rosemblit, C.;Beguelin, W. (...)Elizalde, P.V. Molecular and Cellular Biology. 29(5):1249-1265
"Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis" (2008) Giulianelli, S.;Cerliani, J.P.;Lamb, C.A. (...)Lanari, C. International Journal of Cancer. 123(11):2518-2531
"Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer" (2007) Sacca, P.;Meiss, R.;Casas, G. (...)Vazquez, E. British Journal of Cancer. 97(12):1683-1689
"Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells" (2006) Rodrigues, J.M.;Elias, F.;Montaner, A. (...)Dupont, J. Medicina. 66(1):9-16
"Cytogenetic findings, Trp53 mutations, and hormone responsiveness in a medroxyprogesterone acetate induced murine breast cancer model" (2005) Fabris, V.T.;Benavides, F.;Conti, C. (...)Lanari, C. Cancer Genetics and Cytogenetics. 161(2):130-139
"Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer " (2004) Salatino, M.;Schillaci, R.;Proietti, C.J. (...)Elizalde, P.V. Medicina. 64(2):129-134
"p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells" (2002) Martinez, L.A.;Yang, J.;Vazquez, E.S. (...)Navone, N.M. Carcinogenesis. 23(8):1289-1296
"Actions of immunosuppressor drugs on the development of an experimental ovarian tumor" (2002) Sorianello, E.;Schillaci, R.;Chamson-Reig, A. (...)Libertun, C. Experimental Biology and Medicine. 227(8):658-664
"Involvement of insulin-like growth factors-I and-II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas" (1998) Elizalde, P.V.;Lanari, C.;Molinolo, A.A. (...)Charreau, E.H. Journal of Steroid Biochemistry and Molecular Biology. 67(4):305-317
"Effects of sarcoma 180 growth on interleukin-1 and circulating immune complexes" (1994) Chasseing, N.A.; Eugui, E.M.; Borda, E.S.; Rumi, L. Cancer Investigation. 12(4):390-394
"Studies to determine the possible antitumoral properties of Cobra venom and of Crotoxin Complex A and B" (1988) Baldi, A.;Mordoh, J.;Medrano, E.E. (...)Rumi, L. Medicina. 48(4):337-344
"Cancer and BCG " (1981) Rumi, L.S. Acta Physiologica Latino-Americana. 31(1):25-34